Why Did the Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampus Avoidance in SCLC Not Reveal a Difference?

  • José S A Belderbos*
  • , Dirk K M De Ruysscher
  • , Katrien De Jaeger
  • , Friederike Koppe
  • , Maarten L F Lambrecht
  • , Yolande Lievens
  • , Edith M T Dieleman
  • , Jaap P M Jaspers
  • , Jan P Van Meerbeeck
  • , Fred Ubbels
  • , Magriet Kwint
  • , Marianne Kuenen
  • , Sabine Deprez
  • , Michiel B De Ruiter
  • , Willem Boogerd
  • , Karolina Sikorska
  • , Harm Van Tinteren
  • , Sanne B Schagen
  • *Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Original languageEnglish
Pages (from-to)e42-e45
Number of pages4
JournalJournal of Thoracic Oncology
Volume16
Issue number6
DOIs
Publication statusPublished - Jun 2021

Keywords

  • Cranial Irradiation/adverse effects
  • Hippocampus
  • Humans
  • Lung Neoplasms
  • Small Cell Lung Carcinoma

Cite this